Analyst: Salix could be acquired for $190 per share
September 29, 2014 at 14:50 PM EDT
Analysts at Sterne Agee predict there is a 55 percent probability that Raleigh’s Salix Pharmaceuticals will be acquired at $190 per share...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.